These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5972404)

  • 41. Substituted metatyramines as brain monoamine depletors.
    Carlsson A; Lindqvist M; Wysokowski J; Corrodi H; Junggren U
    Acta Pharm Suec; 1970 Jun; 7(3):293-302. PubMed ID: 5431469
    [No Abstract]   [Full Text] [Related]  

  • 42. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway.
    Coatrieux C; Sanson M; Negre-Salvayre A; Parini A; Hannun Y; Itohara S; Salvayre R; Auge N
    Free Radic Biol Med; 2007 Jul; 43(1):80-9. PubMed ID: 17561096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Involvement of monoamine oxidases in formation of 4-hydroxyphenylethanol, major component of tribulin A].
    Panova NG; Veselovskaia NV; Medvedev AE
    Vopr Med Khim; 1997; 43(3):172-6. PubMed ID: 9273781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Inhibitory monoamine oxidases of the new generation].
    Nowakowska E; Chodera A
    Pol Merkur Lekarski; 1997 Jul; 3(13):1-4. PubMed ID: 9432289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions.
    Tekes K; Magyar K
    Neurobiology (Bp); 2000; 8(3-4):257-64. PubMed ID: 11225517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sympathomimetic effects of MIBG: comparison with tyramine.
    Graefe KH; Bossle F; Wölfel R; Burger A; Souladaki M; Bier D; Dutschka K; Farahati J; Bönisch H
    J Nucl Med; 1999 Aug; 40(8):1342-51. PubMed ID: 10450687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A selective, reversible, competitive inhibitor of monoamine oxidase A containing no nitrogen, with negligible potentiation of tyramine-induced blood pressure rise.
    Harfenist M; McGee DP; White HL
    J Med Chem; 1991 Sep; 34(9):2931-3. PubMed ID: 1895310
    [No Abstract]   [Full Text] [Related]  

  • 50. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [On the effect of various digitalis substances on monoamine oxidase activity in rat, guinea pig and cat brain].
    Popov N; Förster W
    Acta Biol Med Ger; 1966; 17(2):221-31. PubMed ID: 5983237
    [No Abstract]   [Full Text] [Related]  

  • 52. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
    Eisenhofer G; Finberg JP
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyramine stimulates glucose uptake in insulin-sensitive tissues in vitro and in vivo via its oxidation by amine oxidases.
    Morin N; Visentin V; Calise D; Marti L; Zorzano A; Testar X; Valet P; Fischer Y; Carpéné C
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1238-47. PubMed ID: 12438548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.
    Westwood NN; Bryan-Lluka LJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):815-21. PubMed ID: 8246156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site.
    Harfenist M; McGee DP; Reeves MD; White HL
    J Med Chem; 1998 Jun; 41(12):2118-25. PubMed ID: 9622553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C
    Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of MAO-inhibitors on deamination of 3H-norepinephrine in the dog's saphenous vein.
    Verbeuren TJ; Vanhoutte PM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):348-9. PubMed ID: 677971
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of adepren on the rate of cerebral noradrenaline metabolism].
    Tiutiulkova N; Gorancheva Iu
    Eksp Med Morfol; 1978; 17(2):80-3. PubMed ID: 658003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of a series of indole derivatives on monoamine oxidase activity].
    Pidevich IN; Krupinska I; Gryglewski R; Zhmuda A
    Farmakol Toksikol; 1971; 34(6):663-6. PubMed ID: 5139781
    [No Abstract]   [Full Text] [Related]  

  • 60. The uptake and disposition of dl-norepinephrine in perfused rat lung.
    Hughes J; Gillis CN; Bloom FE
    J Pharmacol Exp Ther; 1969 Oct; 169(2):237-48. PubMed ID: 5824606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.